SaNOtize Research and Development Corporation
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From SaNOtize Research and Development Corporation
SaNOtize is in partnering talks with large firms in India to manufacture and distribute its nitric oxide nasal spray for COVID-19. The Canadian company believes the product, which already has an interim approval in Israel, could potentially reduce viral load of SARS-CoV-2 variants, as well as influenza and other respiratory viruses.
- Drug Delivery